tZERO Group, Inc. filed a Form 425 on November 11, 2026, announcing CFTC approval of its subsidiary tZERO DCM, LLC as a Designated Contract Market and the satisfaction of the first earn-out milestone under its proposed merger with FG Imperii Acquisition Corp.
Klarna Group plc filed a Form 6-K on November 12, 2026, announcing the appointment of Chris Koegel as Chief Financial Officer, effective January 1, 2027, subject to regulatory approval.
Francisco Alvarez-Demalde, a director of VTEX, filed a Form 4 on November 12, 2026, reporting the exercise of 182,000 stock options and the subsequent sale of all resulting Class A Common Shares on November 9, 2026.
Timothy Bergwall, SVP and Chief Commercial Officer of Greif, Inc., filed a Form 4 on November 12, 2026, disclosing a sale of 2,000 shares of Class A Common Stock on November 10, 2026, pursuant to a Rule 10b5-1 trading plan.
Steven J. Delahunt, Interim CFO of Cabot Corporation, filed a Form 4 on November 11, 2026, disclosing a disposition of 355 shares of common stock on November 10, 2026, through a tax withholding transaction.
Erica McLaughlin, Executive Vice President and CFO of Cabot Corporation, filed a Form 4 on November 11, 2026, disclosing a disposition of common stock on November 10, 2026.
Lorenzo Flores, SVP and CFO of Lattice Semiconductor Corp, filed a Form 4 on November 12, 2026, reporting a tax-withholding disposition of common stock that occurred on October 10, 2026.
Moog Inc. Chairman John Scannell filed a Form 144 notice on November 12, 2026, disclosing a proposed sale of 3,000 shares of Moog Class A common stock (MOGA) on the New York Stock Exchange.
Karen A. Kalita, SVP and General Counsel of Cabot Corp, filed a Form 4 on November 11, 2026, disclosing a disposition of common stock on November 10, 2026.
Director John W. Kozarich filed a Form 144 notice of proposed sale with the SEC on November 12, 2026, disclosing plans to sell 500 shares of Ligand Pharmaceuticals Inc. common stock.